SCHEMBL13848965

SCHEMBL13848965

Bc1cnn(-c2cc(C(=O)OCC)ccc2C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
ABL1 P00519 2/20 0.42
BCR P11274 2/20 0.42
ALDH1A1 P00352 4/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B2 P37059 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
NPC1 O15118 2/20 0.39
CYP1A2 P05177 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13887410 0.87 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL4013954 0.85 CA12 (0.43) CA12CA1CA2CA7CA9
SCHEMBL4015211 0.82 CYP2C9 (0.48) CA12CA1CA2CA7CA9
SCHEMBL4017487 0.78 MMP2 (0.48) ABL1BCRPABPC1APOBEC3AEIF4H
SCHEMBL4023196 0.77 RXFP1 (0.51) CA12CA1CA2CA7CA9
SCHEMBL16574023 0.75 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL5218434 0.75 NPC1 (0.47) ABL1BCRALDH1A1NPC1PABPC1
SCHEMBL5217843 0.75 NPC1 (0.60) ABL1BCRALDH1A1SMN1; SMN2NPC1
SCHEMBL8354914 0.74 LMNA (0.45) ABL1BCRNPC1LMNAPABPC1
SCHEMBL5217102 0.74 MAPT (0.47) ABL1BCRALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725544-B1 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES BOEHRINGER INGELHEIM PHARMA (US) 2009-05-27 EP disclosed